PMC Links for Gene (Select 54765) - PMC

Kingo Kashimoto, Shuhei Komatsu, Daisuke Ichikawa, Tomohiro Arita, Hirotaka Konishi, Hiroaki Nagata, Hiroki Takeshita, Yukihisa Nishimura, Shoji Hirajima, Tsutomu Kawaguchi, Atsushi Shiozaki, Hitoshi Fujiwara, Kazuma Okamoto, Hitoshi Tsuda, Eigo Otsuji

Cancer Sci. 2012 Nov; 103(11): 2021–2026. Published online 2012 Sep 14. doi: 10.1111/j.1349-7006.2012.02407.x

PMCID:: PMC7659272

Article PDF–369K

Select item 72753594.

Expression of tripartite motif-containing 44 and its prognostic and clinicopathological value in human malignancies:a meta-analysis

Guoliang Xiao, Qiuxi Yang, Ziwei Bao, Haixia Mao, Yi Zhang, Shibu Lin

BMC Cancer. 2020; 20: 525. Published online 2020 Jun 5. doi: 10.1186/s12885-020-07014-w

PMCID:: PMC7275359

Article PDF–3.6M

Select item 64006625.

High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer

Shuang Liu, Fanling Meng, Jing Ding, Hongying Ji, Mu Lin, Jiaqi Zhu, Rong Ma

Biosci Rep. 2019 Mar 29; 39(3): BSR20181639. Prepublished online 2019 Feb 21. Published online 2019 Mar 6. doi: 10.1042/BSR20181639

PMCID:: PMC6400662

Article PDF–888K

Select item 63653836.

TRIM44 promotes quiescent multiple myeloma cell occupancy and survival in the osteoblastic niche via HIF-1α stabilization

Zheng Chen, Tsung-Chin Lin, Xiaohong Bi, Guijin Lu, Brian C. Dawson, Roberto Miranda, L. Jeffrey Medeiros, Ian McNiece, Nami McCarty

Leukemia. 2019; 33(2): 469–486. Published online 2018 Aug 8. doi: 10.1038/s41375-018-0222-x

PMCID:: PMC6365383

Article PDF–2.6M

Select item 62216477.

Correlation between tripartite motif-containing protein 44 protein expression and the prognosis of postoperative patients exhibiting skin squamous cell carcinoma

Jian Wu, Nai-Zhou Guo, Lei-lei Cui, Wei Wang, Cun-quan Xiong, Xue-yan Zhang

Medicine (Baltimore) 2018 Nov; 97(44): e13021. Published online 2018 Nov 2. doi: 10.1097/MD.0000000000013021

PMCID:: PMC6221647

Article PDF–391K

Select item 61720518.

TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway

Dian Xiong, Chun Jin, Xudong Ye, Baiquan Qiu, Xu Jianjun, Shuqiang Zhu, Long Xiang, Haibo Wu, Wu Yongbing

Cancer Sci. 2018 Oct; 109(10): 3080–3092. Published online 2018 Aug 28. doi: 10.1111/cas.13762

PMCID:: PMC6172051

Article PDF–4.1M

Select item 58523539.

Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling

Rui Peng, Peng‐Fei Zhang, Chi Zhang, Xiao‐Yong Huang, Yan‐bing Ding, Bin Deng, Dou‐Sheng Bai, Ya‐Ping Xu

Cancer Med. 2018 Mar; 7(3): 796–808. Published online 2018 Feb 15. doi: 10.1002/cam4.1313

PMCID:: PMC5852353

Article PDF–1.4M

Select item 561858010.

TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling

Hidetaka Kawabata, Kotaro Azuma, Kazuhiro Ikeda, Ikuko Sugitani, Keiichi Kinowaki, Takeshi Fujii, Akihiko Osaki, Toshiaki Saeki, Kuniko Horie-Inoue, Satoshi Inoue

Int J Mol Sci. 2017 Sep; 18(9): 1931. Published online 2017 Sep 8. doi: 10.3390/ijms18091931

PMCID:: PMC5618580

Article PDF–2.2M

Select item 527682711.

A novel prognostic factor TRIM44 promotes cell proliferation and migration, and inhibits apoptosis in testicular germ cell tumor

Yuta Yamada, Ken‐ichi Takayama, Tetsuya Fujimura, Daisaku Ashikari, Daisuke Obinata, Satoru Takahashi, Kazuhiro Ikeda, Shigenori Kakutani, Tomohiko Urano, Hiroshi Fukuhara, Yukio Homma, Satoshi Inoue

Cancer Sci. 2017 Jan; 108(1): 32–41. Published online 2016 Dec 1. doi: 10.1111/cas.13105

PMCID:: PMC5276827

Article PDF–1.8M

Select item 860638712.

YTHDF1 promotes the proliferation, migration, and invasion of prostate cancer cells by regulating TRIM44

Weijian Li, Gaohuang Chen, Zhenyu Feng, Baoyi Zhu, Lilin Zhou, Yuying Zhang, Junyan Mai, Chonghe Jiang, Jianwen Zeng

Genes Genomics. 2021; 43(12): 1413–1421. Published online 2021 Oct 22. doi: 10.1007/s13258-021-01175-z

PMCID:: PMC8606387

Article PDF–4.3M

Select item 706048013.

TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma

Yuta Yamada, Naoki Kimura, Ken‐ichi Takayama, Yusuke Sato, Takashi Suzuki, Kotaro Azuma, Tetsuya Fujimura, Kazuhiro Ikeda, Haruki Kume, Satoshi Inoue

Cancer Sci. 2020 Mar; 111(3): 881–890. Published online 2020 Jan 20. doi: 10.1111/cas.14295

PMCID:: PMC7060480

Article PDF–1.3M

Select item 692822114.

miR-192-5p suppresses the progression of lung cancer bone metastasis by targeting TRIM44

Peng Zou, Menghai Zhu, Chong Lian, Jiaqiang Wang, Zhiquan Chen, Xiaoming Zhang, Yongchao Yang, Xinfeng Chen, Xinhui Cui, Jijun Liu, Hexuan Wang, Qi Wen, Ji Yi

Sci Rep. 2019; 9: 19619. Published online 2019 Dec 23. doi: 10.1038/s41598-019-56018-5

PMCID:: PMC6928221

Article PDF–4.2M

Select item 505869415.

TRIM44 promotes proliferation and metastasis in non-small cell lung cancer via mTOR signaling pathway

Ying Xing, Qingwei Meng, Xuesong Chen, Yanbin Zhao, Wei Liu, Jing Hu, Feng Xue, Xiaoyuan Wang, Li Cai

Oncotarget. 2016 May 24; 7(21): 30479–30491. Published online 2016 Apr 5. doi: 10.18632/oncotarget.8586

PMCID:: PMC5058694

Article PDF–7.3M

Select item 906610016.

TRIM44 promotes BRCA1 functions in HR repair to induce Cisplatin Chemoresistance in Lung Adenocarcinoma by Deubiquitinating FLNA

Shuai Zhang, Mengru Cao, Shi Yan, Yuechao Liu, Weina Fan, Yimeng Cui, Fanglin Tian, Ruixue Gu, Yaowen Cui, Yuning Zhan, Yuanyuan Sun, Ying Xing, Li Cai, Yang Song

Int J Biol Sci. 2022; 18(7): 2962–2979. Published online 2022 Apr 18. doi: 10.7150/ijbs.71283

PMCID:: PMC9066100

Article PDF–6.8M

Select item 974423917.

TRIM44 mediated p62 deubiquitination enhances DNA damage repair by increasing nuclear FLNA and 53BP1 expression

Lin Lyu, Tsung-Chin Lin, Nami McCarty

Oncogene. Author manuscript; available in PMC 2022 Dec 12.

Published in final edited form as: Oncogene. 2021 Aug; 40(32): 5116–5130. Published online 2021 Jul 1. doi: 10.1038/s41388-021-01890-7

PMCID:: PMC9744239

Article PDF–4.4M

Select item 903749218.

TRIM44 links the UPS to SQSTM1/p62-dependent aggrephagy and removing misfolded proteins

Lin Lyu, Zheng Chen, Nami McCarty

Autophagy. 2022; 18(4): 783–798. Published online 2021 Aug 12. doi: 10.1080/15548627.2021.1956105

PMCID:: PMC9037492

Article PDF–6.1M

Select item 338872519.

Genome-wide association study of movement-related adverse antipsychotic effects

Karolina Åberg, Daniel E. Adkins, József Bukszár, Bradley T. Webb, Stanley N. Caroff, Del D. Miller, Jonathan Sebat, Scott Stroup, Ayman H. Fanous, Vladimir I. Vladimirov, Joseph L. McClay, Jeffrey A. Lieberman, Patrick F. Sullivan, Edwin J.C.G. van den Oord

Biol Psychiatry. Author manuscript; available in PMC 2012 Jul 3.

Published in final edited form as: Biol Psychiatry. 2010 Feb 1; 67(3): 279–282. Published online 2009 Oct 28. doi: 10.1016/j.biopsych.2009.08.036

PMCID:: PMC3388725

Article PDF–39K

Select item 643789120.

TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4

Chuan-Yuan Wei, Lu Wang, Meng-Xuan Zhu, Xin-Yi Deng, Dao-He Wang, Si-Min Zhang, Jiang-Hui Ying, Xin Yuan, Qiang Wang, Tian-Fan Xuan, An-Qi He, Fa-Zhi Qi, Jian-Ying Gu

J Exp Clin Cancer Res. 2019; 38: 137. Published online 2019 Mar 28. doi: 10.1186/s13046-019-1138-7